9 results on '"Newton, Florence"'
Search Results
2. Moving Medicine: Development Of An Exercise Oncology Tool For Clinical Practice: 939 Board #173 May 29 3:30 PM - 5:00 PM
- Author
-
Robinson, Rebecca, Joshi, Kush, Reid, Hamish, Jones, Natasha, Loosemore, Mike, Hornby, Katy, and Newton, Florence
- Published
- 2019
- Full Text
- View/download PDF
3. How Can I Recover Commercial Rent Arrears? Part 1
- Author
-
Newton, Florence
- Subjects
Commercial leases -- Laws, regulations and rules ,Rents (Property) -- Laws, regulations and rules ,Government regulation ,Business, international - Abstract
What is Commercial Rent Arrears Recovery ('CRAR') and When Can I Use It? Commercial Rent Arrears Recovery (otherwise known as 'CRAR') was introduced in April 2014 by virtue of Part [...]
- Published
- 2022
4. Commentary on a recent article—“A prostacyclin analogue, Iloprost, protects from bleomycin-induced fibrosis in mice” Zhu Y et al. Respir Res. 2010 Mar 20;11(1):34
- Author
-
Stratton, Richard and Newton, Florence
- Published
- 2010
- Full Text
- View/download PDF
5. Accounting for multiple injuries does not improve the Functional Movement Screen (FMS™) as a tool to identify injury risk among English Premier League academy football players: a 3-season prospective cohort study
- Author
-
McCunn, Robert, primary, Blackburne, Colin, additional, Newton, Florence, additional, Carroll, Noel, additional, Bakken, Arnhild, additional, Ryan, Desmond, additional, and McCall, Alan, additional
- Published
- 2019
- Full Text
- View/download PDF
6. Scleroderma and related disorders: 223. Long Term Outcome in a Contemporary Systemic Sclerosis Cohort
- Author
-
Nihtyanova, Svetlana, Ong, Voon, Black, Carol, Denton, Chris, Lutalo, Pamela, Shattles, Warren, Jones, Hugh, Nouri, Reem, Hepburn, Alastair, Chard, Michael, Horwood, Natalie, Lynn, Myo, Duke, Oliver, Kiely, Patrick, Zouita, Louisa, Davies, Ursula, Hughes, Rod, Lloyd, Mark, Nikitorowicz Buniak, Joanna, Shiwen, Xu, Abraham, David, Stratton, Richard, Hügle, Thomas, Schuetz, Philipp, Daikeler, Thomas, Tyndall, Alan, Matucci-Cerinic, Marco, Walker, Ulrich A., van Laar, Jacob M., Pauling, John D., Flower, Victoria, McHugh, Neil, Liu, Shangxi, Leask, Andrew, Aden, Nima, Khan, Korsa, Hoyles, Rachel, Bhagat, Shweta, Drummond, Tom, Goh, Cyndi, Busch, Robert, Hall, Frances, Meyer, Paul, Moinzadeh, Pia, Krieg, Thomas, Hellmich, Martin, Brinckmann, Juergen, Neumann, Elena, Mueller-Ladner, Ulf, Kreuter, Alexander, Dumitresco, Daniel, Rosenkranz, Stefan, Hunzelmann, Nicolas, Binai, Nadine, Huegle, Thomas, van Laar, Jaap, Sonnylal, S., Tam, A., Jones, H., Leask, A., Norman, J., Denton, C., de Crombrugghe, B., Abraham, D., Chighizola, Cecilia B., Luigi Meroni, Pier, Coghlan, Gerry, Newton, Florence, Derrett-Smith, Emma C., Dooley, Audrey, Baliga, Reshma, Hobbs, Adrian, MacAllister, Raymond, Futema, Marta, Pantelidis, Panagiotis, Renzoni, Elizabeth, Schreiber, Benjamin E., Coghlan, Gerry J., Wells, Athol U., Welsh, Ken, Fonseca, Carmen, Ponticos, Markella, Wells, Athol, Guillevin, Loic, Schwierin, Barbara, Rosenberg, Daniel, Silkey, Mariabeth, Parapuram, Sunil, Shi-wen, Xu, Denton, Christopher, Ahmed Abdi, Bahja, Xu, Shiwen, Nihtyanova, Svetlana, Ong, Voon, Black, Carol, Denton, Chris, Lutalo, Pamela, Shattles, Warren, Jones, Hugh, Nouri, Reem, Hepburn, Alastair, Chard, Michael, Horwood, Natalie, Lynn, Myo, Duke, Oliver, Kiely, Patrick, Zouita, Louisa, Davies, Ursula, Hughes, Rod, Lloyd, Mark, Nikitorowicz Buniak, Joanna, Shiwen, Xu, Abraham, David, Stratton, Richard, Hügle, Thomas, Schuetz, Philipp, Daikeler, Thomas, Tyndall, Alan, Matucci-Cerinic, Marco, Walker, Ulrich A., van Laar, Jacob M., Pauling, John D., Flower, Victoria, McHugh, Neil, Liu, Shangxi, Leask, Andrew, Aden, Nima, Khan, Korsa, Hoyles, Rachel, Bhagat, Shweta, Drummond, Tom, Goh, Cyndi, Busch, Robert, Hall, Frances, Meyer, Paul, Moinzadeh, Pia, Krieg, Thomas, Hellmich, Martin, Brinckmann, Juergen, Neumann, Elena, Mueller-Ladner, Ulf, Kreuter, Alexander, Dumitresco, Daniel, Rosenkranz, Stefan, Hunzelmann, Nicolas, Binai, Nadine, Huegle, Thomas, van Laar, Jaap, Sonnylal, S., Tam, A., Jones, H., Leask, A., Norman, J., Denton, C., de Crombrugghe, B., Abraham, D., Chighizola, Cecilia B., Luigi Meroni, Pier, Coghlan, Gerry, Newton, Florence, Derrett-Smith, Emma C., Dooley, Audrey, Baliga, Reshma, Hobbs, Adrian, MacAllister, Raymond, Futema, Marta, Pantelidis, Panagiotis, Renzoni, Elizabeth, Schreiber, Benjamin E., Coghlan, Gerry J., Wells, Athol U., Welsh, Ken, Fonseca, Carmen, Ponticos, Markella, Wells, Athol, Guillevin, Loic, Schwierin, Barbara, Rosenberg, Daniel, Silkey, Mariabeth, Parapuram, Sunil, Shi-wen, Xu, Denton, Christopher, Ahmed Abdi, Bahja, and Xu, Shiwen
- Abstract
Background: We have previously compared outcome in two groups of systemic sclerosis (SSc) patients with disease onset a decade apart and we reported data on 5 year survival and cumulative incidence of organ disease in a contemporary SSc cohort. The present study examines longer term outcome in an additional cohort of SSc followed for 10 years. Methods: We have examined patients with disease onset between years 1995 and 1999 allowing for at least 10 years of follow-up in a group that has characteristics representative for the patients we see in contemporary clinical practice. Results: Of the 398 patients included in the study, 252 (63.3%) had limited cutaneous (lc) SSc and 146 (36.7%) had diffuse cutaneous (dc) SSc. The proportion of male patients was higher among the dcSSc group (17.1% v 9.9%, p = 0.037) while the mean age of onset was significantly higher among lcSSc patients (50 ± 13 v 46 ± 13 years ± SD, p = 0.003). During a 10 year follow-up from disease onset, 45% of the dcSSc and 21% of the lcSSc subjects developed clinically significant pulmonary fibrosis, p < 0.001. Among them approximately half reached the endpoint within the first 3 years (23% of dcSSc and 10% of lcSSc) and over three quarters within the first 5 years (34% and 16% respectively). There was a similar incidence of pulmonary hypertension (PH) in the two subsets with a steady rate of increase over time. At 10 years 13% of dcSSc and 15% of lcSSc subjects had developed PH (p=0.558), with the earliest cases observed within the first 2 years of disease. Comparison between subjects who developed PH in the first and second 5 years from disease onset demonstrated no difference in demographic or clinical characteristics, but 5-year survival from PH onset was better among those who developed this complication later in their disease (49% v 24%), with a strong trend towards statistical significance (p = 0.058). Incidence of SSc renal crisis (SRC) was significantly higher among the dcSSc patients (12% v 4%
- Published
- 2017
7. Functional Movement Screen (FMS™) score does not predict injury in English Premier League youth academy football players
- Author
-
Newton, Florence, primary, McCall, Alan, additional, Ryan, Desmond, additional, Blackburne, Colin, additional, aus der Fünten, Karen, additional, Meyer, Tim, additional, Lewin, Colin, additional, and McCunn, Robert, additional
- Published
- 2017
- Full Text
- View/download PDF
8. Florence Huntington Newton Bookplate
- Author
-
Stone, Wilbur Macey, Messenger, Maria Gerard, 1849-1937, Newton, Florence Huntington, Stone, Wilbur Macey, Messenger, Maria Gerard, 1849-1937, and Newton, Florence Huntington
- Abstract
Pictorial bookplate, inscribed: "Florence Huntington Newton's book \ Date [blank]". Depicts text with a stack of books at the top. The artist's initials and the year are visible in the bottom-left and right corners, respectively.
- Published
- 1899
9. Scleroderma and related disorders: 223. Long Term Outcome in a Contemporary Systemic Sclerosis Cohort
- Author
-
Nihtyanova, Svetlana, Ong, Voon, Black, Carol, Denton, Chris, Lutalo, Pamela, Shattles, Warren, Jones, Hugh, Nouri, Reem, Hepburn, Alastair, Chard, Michael, Horwood, Natalie, Lynn, Myo, Duke, Oliver, Kiely, Patrick, Zouita, Louisa, Davies, Ursula, Hughes, Rod, Lloyd, Mark, Nikitorowicz Buniak, Joanna, Shiwen, Xu, Abraham, David, Stratton, Richard, Hügle, Thomas, Schuetz, Philipp, Daikeler, Thomas, Tyndall, Alan, Matucci-Cerinic, Marco, Walker, Ulrich A., van Laar, Jacob M., Pauling, John D., Flower, Victoria, McHugh, Neil, Liu, Shangxi, Leask, Andrew, Aden, Nima, Khan, Korsa, Hoyles, Rachel, Bhagat, Shweta, Drummond, Tom, Goh, Cyndi, Busch, Robert, Hall, Frances, Meyer, Paul, Moinzadeh, Pia, Krieg, Thomas, Hellmich, Martin, Brinckmann, Juergen, Neumann, Elena, Mueller-Ladner, Ulf, Kreuter, Alexander, Dumitresco, Daniel, Rosenkranz, Stefan, Hunzelmann, Nicolas, Binai, Nadine, Huegle, Thomas, van Laar, Jaap, Sonnylal, S., Tam, A., Jones, H., Leask, A., Norman, J., Denton, C., de Crombrugghe, B., Abraham, D., Chighizola, Cecilia B., Luigi Meroni, Pier, Coghlan, Gerry, Newton, Florence, Derrett-Smith, Emma C., Dooley, Audrey, Baliga, Reshma, Hobbs, Adrian, MacAllister, Raymond, Futema, Marta, Pantelidis, Panagiotis, Renzoni, Elizabeth, Schreiber, Benjamin E., Coghlan, Gerry J., Wells, Athol U., Welsh, Ken, Fonseca, Carmen, Ponticos, Markella, Wells, Athol, Guillevin, Loic, Schwierin, Barbara, Rosenberg, Daniel, Silkey, Mariabeth, Parapuram, Sunil, Shi-wen, Xu, Denton, Christopher, Ahmed Abdi, Bahja, Xu, Shiwen, Nihtyanova, Svetlana, Ong, Voon, Black, Carol, Denton, Chris, Lutalo, Pamela, Shattles, Warren, Jones, Hugh, Nouri, Reem, Hepburn, Alastair, Chard, Michael, Horwood, Natalie, Lynn, Myo, Duke, Oliver, Kiely, Patrick, Zouita, Louisa, Davies, Ursula, Hughes, Rod, Lloyd, Mark, Nikitorowicz Buniak, Joanna, Shiwen, Xu, Abraham, David, Stratton, Richard, Hügle, Thomas, Schuetz, Philipp, Daikeler, Thomas, Tyndall, Alan, Matucci-Cerinic, Marco, Walker, Ulrich A., van Laar, Jacob M., Pauling, John D., Flower, Victoria, McHugh, Neil, Liu, Shangxi, Leask, Andrew, Aden, Nima, Khan, Korsa, Hoyles, Rachel, Bhagat, Shweta, Drummond, Tom, Goh, Cyndi, Busch, Robert, Hall, Frances, Meyer, Paul, Moinzadeh, Pia, Krieg, Thomas, Hellmich, Martin, Brinckmann, Juergen, Neumann, Elena, Mueller-Ladner, Ulf, Kreuter, Alexander, Dumitresco, Daniel, Rosenkranz, Stefan, Hunzelmann, Nicolas, Binai, Nadine, Huegle, Thomas, van Laar, Jaap, Sonnylal, S., Tam, A., Jones, H., Leask, A., Norman, J., Denton, C., de Crombrugghe, B., Abraham, D., Chighizola, Cecilia B., Luigi Meroni, Pier, Coghlan, Gerry, Newton, Florence, Derrett-Smith, Emma C., Dooley, Audrey, Baliga, Reshma, Hobbs, Adrian, MacAllister, Raymond, Futema, Marta, Pantelidis, Panagiotis, Renzoni, Elizabeth, Schreiber, Benjamin E., Coghlan, Gerry J., Wells, Athol U., Welsh, Ken, Fonseca, Carmen, Ponticos, Markella, Wells, Athol, Guillevin, Loic, Schwierin, Barbara, Rosenberg, Daniel, Silkey, Mariabeth, Parapuram, Sunil, Shi-wen, Xu, Denton, Christopher, Ahmed Abdi, Bahja, and Xu, Shiwen
- Abstract
Background: We have previously compared outcome in two groups of systemic sclerosis (SSc) patients with disease onset a decade apart and we reported data on 5 year survival and cumulative incidence of organ disease in a contemporary SSc cohort. The present study examines longer term outcome in an additional cohort of SSc followed for 10 years. Methods: We have examined patients with disease onset between years 1995 and 1999 allowing for at least 10 years of follow-up in a group that has characteristics representative for the patients we see in contemporary clinical practice. Results: Of the 398 patients included in the study, 252 (63.3%) had limited cutaneous (lc) SSc and 146 (36.7%) had diffuse cutaneous (dc) SSc. The proportion of male patients was higher among the dcSSc group (17.1% v 9.9%, p = 0.037) while the mean age of onset was significantly higher among lcSSc patients (50 ± 13 v 46 ± 13 years ± SD, p = 0.003). During a 10 year follow-up from disease onset, 45% of the dcSSc and 21% of the lcSSc subjects developed clinically significant pulmonary fibrosis, p < 0.001. Among them approximately half reached the endpoint within the first 3 years (23% of dcSSc and 10% of lcSSc) and over three quarters within the first 5 years (34% and 16% respectively). There was a similar incidence of pulmonary hypertension (PH) in the two subsets with a steady rate of increase over time. At 10 years 13% of dcSSc and 15% of lcSSc subjects had developed PH (p=0.558), with the earliest cases observed within the first 2 years of disease. Comparison between subjects who developed PH in the first and second 5 years from disease onset demonstrated no difference in demographic or clinical characteristics, but 5-year survival from PH onset was better among those who developed this complication later in their disease (49% v 24%), with a strong trend towards statistical significance (p = 0.058). Incidence of SSc renal crisis (SRC) was significantly higher among the dcSSc patients (12% v 4%
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.